Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-305 for Inflammation and Pain After Cataract Surgery
NCT03192150Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-operative inflammation and postoperative pain comparing ISV-305 with Vehicle (2 arms). Primary endpoint: Number of Participants With Anterior Chamber Cell Grade 0 in Study Eye at Day 15. Started Jan 2018; status: completed.
02
Drugs
DexaSite
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT03192150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192150.